MRC1 and colitis: In line with these findings, we found that MSCs significantly ameliorated the clinical and histopathological severity of DSS-induced colitis (Figure 1) that correlated with increased serum levels of IL-10 (Figure 2) and increased percentage of F4/80+CD206+ alternatively activated macrophages in colon (Figure 3).